http://finviz.com/chart.ashx?t=CRBP&ty=c&ta=1&p=d
Post# of 21
Corbus Pharmaceuticals Holdings, Inc., a clinical stage pharmaceutical company, focuses on the development and commercialization of novel therapeutics to treat inflammatory and fibrotic diseases. Its lead product candidate includes Resunab, a novel oral endocannabinoid-mimetic drug, which is in Phase 2 clinical trials for the treatment of cystic fibrosis, systemic sclerosis, and skin-predominant dermatomyositis diseases. The company is based in Norwood, Massachusetts.
Don't be afraid to be outnumbered. Pigeons flock together. Eagle fly alone